Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2012, Article ID 637986, 10 pages
http://dx.doi.org/10.1155/2012/637986
Research Article

Association between P2X7 Receptor Polymorphisms and Bone Status in Mice

1Research Centre of Ageing and Osteoporosis, Departments of Diagnostics and Medicine, Glostrup University Hospital, 2600 Glostrup, Denmark
2Osteoporosis and Bone Metabolic Unit, Departments of Endocrinology and Clinical Biochemistry, Hvidovre University Hospital, 2650 Hvidovre, Denmark
3Department of Internal Medicine, Washington University School of Medicine and the St. Louis Veterans Affairs Medical Center, St. Louis, MO 63110, USA

Received 31 March 2012; Accepted 28 May 2012

Academic Editor: Elena Adinolfi

Copyright © 2012 Susanne Syberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Dixon and S. M. Sims, “P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development,” Drug Development Research, vol. 49, no. 3, pp. 187–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. W. Grol, N. Panupinthu, J. Korcok, S. M. Sims, and S. J. Dixon, “Expression, signaling, and function of P2X7 receptors in bone,” Purinergic Signalling, vol. 5, no. 2, pp. 205–221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Z. Ke, H. Qi, A. F. Weidema et al., “Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption,” Molecular Endocrinology, vol. 17, no. 7, pp. 1356–1367, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Li, D. Liu, H. Z. Ke, R. L. Duncan, and C. H. Turner, “The P2X7 nucleotide receptor mediates skeletal mechanotransduction,” Journal of Biological Chemistry, vol. 280, no. 52, pp. 42952–42959, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Gartland, K. A. Buckley, R. A. Hipskind et al., “Multinucleated osteoclast formation in vivo and in vitro by P2X 7 receptor-deficient mice,” Critical Reviews in Eukaryotic Gene Expression, vol. 13, no. 2-4, pp. 243–253, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. W. B. Bowler, K. A. Buckley, A. Gartland, R. A. Hipskind, G. Bilbe, and J. A. Gallagher, “Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling,” Bone, vol. 28, no. 5, pp. 507–512, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. North, “Molecular physiology of P2X receptors,” Physiological Reviews, vol. 82, no. 4, pp. 1013–1067, 2002. View at Google Scholar · View at Scopus
  8. L. N. Naemsch, S. J. Dixon, and S. M. Sims, “Activity-dependent Development of P2X7 Current and Ca2+ Entry in Rabbit Osteoclasts,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 39107–39114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Surprenant, F. Rassendren, E. Kawashima, R. A. North, and G. Buell, “The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7),” Science, vol. 272, no. 5262, pp. 735–738, 1996. View at Google Scholar · View at Scopus
  10. D. Ferrari, P. Chiozzi, S. Falzoni et al., “Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages,” Journal of Immunology, vol. 159, no. 3, pp. 1451–1458, 1997. View at Google Scholar · View at Scopus
  11. D. Ferrari, M. Los, M. K. A. Bauer, P. Vandenabeele, S. Wesselborg, and K. Schulze-Osthoff, “P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death,” FEBS Letters, vol. 447, no. 1, pp. 71–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. B. J. Gu, W. Zhang, R. A. Worthington et al., “A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor,” Journal of Biological Chemistry, vol. 276, no. 14, pp. 11135–11142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Ohlendorff, C. L. Tofteng, J.-E. B. Jensen et al., “Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment,” Pharmacogenetics and Genomics, vol. 17, no. 7, pp. 555–567, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. N. R. Jørgensen, Z. Henriksen, O. H. Sørensen, E. F. Eriksen, R. Civitelli, and T. H. Steinberg, “Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors,” Journal of Biological Chemistry, vol. 277, no. 9, pp. 7574–7580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gartland, K. A. Buckley, R. A. Hipskind et al., “Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice,” Critical Reviews in Eukaryotic Gene Expression, vol. 13, no. 2-4, pp. 243–253, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. L. C. Denlinger, J. A. Sommer, K. Parker et al., “Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function,” Journal of Immunology, vol. 171, no. 3, pp. 1304–1311, 2003. View at Google Scholar · View at Scopus
  17. J. F. Hiken and T. H. Steinberg, “ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells,” American Journal of Physiology, Cell Physiology, vol. 287, no. 2, pp. C403–C412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Hoebertz, T. R. Arnett, and G. Burnstock, “Regulation of bone resorption and formation by purines and pyrimidines,” Trends in Pharmacological Sciences, vol. 24, no. 6, pp. 290–297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. Morrison, L. Turin, B. F. King, G. Burnstock, and T. R. Arnett, “ATP is a potent stimulator of the activation and formation of rodent osteoclasts,” Journal of Physiology, vol. 511, no. 2, pp. 495–500, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Panupinthu, J. T. Rogers, L. Zhao et al., “P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis,” Journal of Cell Biology, vol. 181, no. 5, pp. 859–871, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Panupinthu, L. Zhao, F. Possmayer, H. Z. Ke, S. M. Sims, and S. J. Dixon, “P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid,” Journal of Biological Chemistry, vol. 282, no. 5, pp. 3403–3412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Sluyter, A. N. Shemon, and J. S. Wiley, “Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1β release from human monocytes,” Journal of Immunology, vol. 172, no. 6, pp. 3399–3405, 2004. View at Google Scholar · View at Scopus
  23. I. P. Chessell, J. P. Hatcher, C. Bountra et al., “Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain,” Pain, vol. 114, no. 3, pp. 386–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Adriouch, C. Dox, V. Welge, M. Seman, F. Koch-Nolte, and F. Haag, “Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor,” Journal of Immunology, vol. 169, no. 8, pp. 4108–4112, 2002. View at Google Scholar · View at Scopus
  25. H. Le Stunff, R. Auger, J. Kanellopoulos, and M. N. Raymond, “The Pro-451 to leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes,” Journal of Biological Chemistry, vol. 279, no. 17, pp. 16918–16926, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Solle, J. Labasi, D. G. Perregaux et al., “Altered cytokine production in mice lacking P2X7 receptors,” Journal of Biological Chemistry, vol. 276, no. 1, pp. 125–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. S. R. J. Taylor, M. Gonzalez-Begne, D. K. Sojka et al., “Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses,” Journal of Leukocyte Biology, vol. 85, no. 6, pp. 978–986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nicke, Y. H. Kuan, M. Masin et al., “A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice,” Journal of Biological Chemistry, vol. 284, no. 38, pp. 25813–25822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. R. Hansen, C. K. Nielsen, A. Nasser et al., “P2X7 receptor-deficient mice are susceptible to bone cancer pain,” Pain, vol. 152, no. 8, pp. 1766–1776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. W. G. Beamer, L. R. Donahue, C. J. Rosen, and D. J. Baylink, “Genetic variability in adult bone density among inbred strains of mice,” Bone, vol. 18, no. 5, pp. 397–403, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Furlan, C. Galbiati, N. R. Jorgensen et al., “Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function,” Journal of Bone and Mineral Research, vol. 22, no. 9, pp. 1387–1396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Wu, M. A. McKenna, X. U. Feng, T. R. Nagy, and J. M. McDonald, “Osteoclast apoptosis: the role of Fas in vivo and in vivo,” Endocrinology, vol. 144, no. 12, pp. 5545–5555, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Gartland, K. A. Buckley, W. B. Bowler, and J. A. Gallagher, “Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro,” Calcified Tissue International, vol. 73, no. 4, pp. 361–369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Korcok, L. N. Raimundo, H. Z. Ke, S. M. Sims, and S. J. Dixon, “Extracellular nucleotides act through P2X7 receptors to activate NF-κB in osteoclasts,” Journal of Bone and Mineral Research, vol. 19, no. 4, pp. 642–651, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Iglesias, S. Locovei, A. Roque et al., “P2X7 receptor-Pannexin1 complex: pharmacology and signaling,” American Journal of Physiology, Cell Physiology, vol. 295, no. 3, pp. C752–C760, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Locovei, E. Scemes, F. Qiu, D. C. Spray, and G. Dahl, “Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex,” FEBS Letters, vol. 581, no. 3, pp. 483–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Brough, P. Pelegrin, and N. J. Rothwell, “Pannexin-1-dependent caspase-1 activation and secretion of IL-1β is regulated by zinc,” European Journal of Immunology, vol. 39, no. 2, pp. 352–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Pelegrin and A. Surprenant, “Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor,” EMBO Journal, vol. 25, no. 21, pp. 5071–5082, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. D. N. Tatakis, “Interleukin-1 and bone metabolism: a review,” Journal of Periodontology, vol. 64, no. 5, supplement, pp. 416–431, 1993. View at Google Scholar · View at Scopus
  40. H. L. Uy, M. Dallas, J. W. Calland, B. F. Boyce, G. R. Mundy, and G. D. Roodman, “Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage,” Journal of Bone and Mineral Research, vol. 10, no. 2, pp. 295–301, 1995. View at Google Scholar · View at Scopus
  41. R. Coutinho-Silva, T. Robson, P. Beales, and G. Burnstock, “Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes,” Autoimmunity, vol. 40, no. 2, pp. 108–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. B. L. Riggs, S. Khosla, and L. J. Melton, “Sex steroids and the construction and conservation of the adult skeleton,” Endocrine Reviews, vol. 23, no. 3, pp. 279–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. U. T. Iwaniec, D. Yuan, R. A. Power, and T. J. Wronski, “Strain-dependent variations in the response of cancellous bone to ovariectomy in mice,” Journal of Bone and Mineral Research, vol. 21, no. 7, pp. 1068–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. L. Bouxsein, K. S. Myers, K. L. Shultz, L. R. Donahue, C. J. Rosen, and W. G. Beamer, “Ovariectomy-induced bone loss varies among inbred strains of mice,” Journal of Bone and Mineral Research, vol. 20, no. 7, pp. 1085–1092, 2005. View at Publisher · View at Google Scholar · View at Scopus